[Featured Stock] Lunit, with Record-High Sales, Surges Over 16%

The stock price of Lunit, a medical artificial intelligence (AI) company that recorded the highest sales ever last year, is showing strength. As of 11:03 AM on the 16th, Lunit is trading at 68,000 won, up 9,600 won (16.44%) compared to the previous trading day.

The day before, Lunit announced that it recorded sales of 25.08024 billion won and an operating loss of 42.18362 billion won last year based on consolidated financial statements. Sales increased by 80.9% compared to the previous year, marking the highest sales ever. The operating loss also narrowed for the first time since the company's founding. It improved by 16.7% compared to the 50.7 billion won operating loss in 2022. Overseas sales played a significant role in the performance improvement.

On the same day, researchers Jonghyun Park and Jungwoo Lee from Daol Investment & Securities said, "With sales diversified across various new drug development companies, Lunit's sales this year are expected to reach 40 billion won, a 60% increase from last year, and the operating loss is expected to decrease to 30 billion won compared to last year," adding, "We are pursuing the acquisition of Volpara, targeting May. After the acquisition, direct sales of the breast mammography image analysis solution 'Lunit Insight MMG' in North America will be possible, securing additional potential for sales expansion."